|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1988-11-14
|
|
pubmed:abstractText |
Fifteen patients with recurrent primary brain tumors were treated with fludarabine phosphate. There were no responses seen. Toxicity was mild and primarily hematological. Fludarabine phosphate would appear to be ineffective in recurrent gliomas.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0277-3732
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
586-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:2459951-Adult,
pubmed-meshheading:2459951-Aged,
pubmed-meshheading:2459951-Antimetabolites, Antineoplastic,
pubmed-meshheading:2459951-Arabinonucleotides,
pubmed-meshheading:2459951-Brain Neoplasms,
pubmed-meshheading:2459951-Drug Administration Schedule,
pubmed-meshheading:2459951-Female,
pubmed-meshheading:2459951-Glioma,
pubmed-meshheading:2459951-Humans,
pubmed-meshheading:2459951-Male,
pubmed-meshheading:2459951-Middle Aged,
pubmed-meshheading:2459951-Neoplasm Recurrence, Local,
pubmed-meshheading:2459951-Vidarabine Phosphate
|
|
pubmed:year |
1988
|
|
pubmed:articleTitle |
Evaluation of fludarabine phosphate in patients with recurrent glioma.
|
|
pubmed:affiliation |
Mayo Clinic, Rochester, Minnesota.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
